Pacira BioSciences, Inc.

82P.F·Frankfurt·Healthcare
Compare
31.40−0.60 (−1.88%)today
As of Nov 5, 8:48 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close32.00
Open31.40
Day range—
52-week range15.4032.40
Off day high0.00%
Off 52-week high−3.09%
Volume370
Avg. volume (3M)0.00
Market cap1.25B
EPS (TTM)0.3000
Forward P/E8.03
P/E ratio (TTM)104.67
Dividend yield—
Beta (5Y)0.22
Shares outstanding39.91M
Short interest—
Earnings dateNov 5, 2026 (est.)
Analyst target—
Profit margin1.96%

Against its peers

Compare in full ›
82P.F COLL 42C.SI ALVO 2M7C.F AQST
Market cap 1.25B 770.59M 515.12M 1.67B 2.87B 476.94M
P/E (TTM) 104.7 18.6 — — 14.8 —
Forward P/E 8.0 3.3 247.4 20.3 — -6.7
Price/book 2.1 2.5 33.6 -8.7 1.2 -6.7
Dividend yield — — — — 3.42% —
1-year change +72.97% −33.81% +259.26% −7.71% −24.84% −38.01%
Today −1.88% −0.25% −3.09% +2.86% +2.61% −2.06%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All 82P.F news ›
Stock Titan·Negative

Pacira BioSciences: DOMA reports 0% ownership

Seven investors report stakes below 5% in Pacira BioSciences (PCRX). Stock Titan - [SCHEDULE 13D/A] Pacira BioSciences, Inc. Amended Major Shareholder Report Pacira BioSciences: DOMA reports 0% ownership The ownership-percentage…

Seeking Alpha·Positive

Pacira BioSciences jumps 44% on Viatris acquisition deal

Pacira BioSciences (PCRX) stock surged 44% after Viatris’ $36.50/share buyout deal. SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication. yalax/iStock via…

From the 4Search news index, newest first.

In the news

45mentions in 30 days
45with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 45 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance